Skip to content

Role of tranexamic acid in reducing blood loss in hip fracture surgeries

Intravenous administration versus local infiltration of tranexamic acid in patients undergoing internal fixation for intertrochanteric fractures ââ?¬â?? A randomized, prospective, double blind, superiority trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021667
Enrollment
120
Registered
2019-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S721- Pertrochanteric fracture

Interventions

Intervention1: Intravenous tranexamic acid: 2 doses of slow infusion of TXA 10 mg per kg body weight, 10 minutes prior to incision and at two hours from first dose Intervention2: Local tranexamic acid

Sponsors

Sri Sathya Sai Institute of Higher Medical Sciences Prasanthigram
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Evans types 1 and 2 2. Internal fixation by Dynamic Hip Screw

Exclusion criteria

Exclusion criteria: 1. Fractures managed with cephalomedullary nails or other surgical modalities. 2. Use of antiplatelet agents or anticoagulants at the time of admission 3. History of cardiac disease or cerebrovascular diseases 4. Documented allergy to TXA 5. History of DVT or pulmonary embolus 6. Hepatic dysfunction 7. Renal dysfunction 8. Derangement of blood coagulation parameters 9. History of malignancy

Design outcomes

Secondary

MeasureTime frame
Any complicationsTimepoint: 6 weeks from surgery;No. of packed cells transfused postoperativelyTimepoint: 6 weeks;Total, visible and hidden blood lossesTimepoint: 5th postoeprative day

Primary

MeasureTime frame
Hb fall on day 5 after accounting for intraoperative and post-operative transfusionTimepoint: Hb fall on day 5 after accounting for intraoperative and post-operative transfusion

Countries

India

Contacts

Public ContactKoushik Narayan Subramanyam

Sri Sathya Sai Institute of Higher Medical Sciences - Prasanthigram

drkoushik@hotmail.com9491629620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026